The Raeven Review

Cognitive Health

Early Signs of Dementia and When to See a Doctor About Memory

A physician's guide to telling normal aging from early warning signs, what causes of memory change are treatable, how an evaluation works, and why acting early on Alzheimer's risk matters.

By Dr. Marissa McCarthyNovember 17, 20269 min read
An older couple sitting together at a sunlit kitchen table, the man writing in a notebook while the woman looks on.

Almost everyone forgets a name or misplaces their keys. Families often wonder when those moments stop being ordinary and start being worth a conversation with a physician. The answer matters more today than it once did, because many causes of memory change are treatable, and a meaningful share of dementia risk is linked to factors we can address.

Normal aging versus a warning sign

Normal aging tends to slow recall without erasing it: a word comes back later, an appointment is remembered with a reminder. Warning signs are changes that disrupt daily life or represent a clear decline from a person's own baseline.

Changes worth discussing with a physician

Asking the same questions repeatedly; difficulty following a conversation or a familiar recipe; trouble managing bills or medications; getting lost in familiar places; new difficulty with planning or judgment; withdrawal from work or social activities; and personality or mood changes such as new anxiety, apathy, or irritability. Often a spouse or adult child notices these before the person does.

“The most useful question is not whether someone forgets, but whether they are changing.”

Mild cognitive impairment

Between normal aging and dementia sits mild cognitive impairment: measurable decline in memory or thinking while independence is preserved. It is common after age 65, and not everyone with it progresses; some people remain stable and some improve, particularly when a reversible cause is found[1].

Causes of memory change that can be treated

A thorough evaluation looks for contributors that are not dementia at all, or that make it worse: untreated sleep apnea, depression and anxiety, thyroid disease, vitamin B12 deficiency, poorly controlled diabetes or blood pressure, hearing loss, prior head injury, and medications with sedating or anticholinergic effects. Addressing these can sharpen thinking on its own.

Risk that can be modified

The 2024 Lancet Commission estimated that nearly half of dementia cases worldwide may be associated with fourteen modifiable risk factors, including physical inactivity, hypertension, diabetes, hearing and vision loss, high LDL cholesterol, smoking, excess alcohol, social isolation, depression, and traumatic brain injury[2]. These are population estimates, not a promise for any one person, but they explain why earlier attention to cardiovascular, metabolic, and sleep health is part of brain care.

Why an early evaluation matters now

Diagnosis has become more precise. Blood and imaging biomarkers can now help identify Alzheimer's biology, and FDA-approved antibody therapies such as lecanemab and donanemab modestly slowed decline in early-stage Alzheimer's disease in clinical trials [3][4]. These treatments carry real risks and are appropriate only for selected patients at an early stage, which is one more reason not to wait.

What a cognitive evaluation includes

At Raeven Health, Dr. Marissa McCarthy evaluates memory and cognitive concerns by telemedicine for Florida residents, including families in Tampa, Sarasota, Orlando, and Miami. A visit reviews history with the patient and, ideally, a family member; medications; sleep, mood, and hearing; vascular and metabolic risk; and structured cognitive screening. From there, a personalized plan may include laboratory testing, coordination of imaging or neuropsychological testing, and a long-term strategy for brain health. Labs, imaging, and medications are billed separately.

Medical Disclaimer

Raeven Review content is written to help patients understand the research and have better conversations with their physicians. It reflects published evidence at the time of writing, which may change, and is not a substitute for individualized medical evaluation. Reading this article does not establish a physician-patient relationship with Dr. Marissa McCarthy or Raeven Health. Medications and therapies discussed may not be appropriate for you, and some compounds mentioned are not FDA approved; their mention is not an endorsement or recommendation. Raeven Health provides care only to established patients after a telemedicine evaluation, for Florida residents. Results vary and no outcome is guaranteed.

References

  1. 1.Petersen, R. C., Lopez, O., Armstrong, M. J., et al. Practice guideline update summary: mild cognitive impairment. Neurology. 2018;90(3):126-135. Source
  2. 2.Livingston, G., Huntley, J., Liu, K. Y., et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572-628. Source
  3. 3.van Dyck, C. H., Swanson, C. J., Aisen, P., et al. Lecanemab in early Alzheimer's disease. New England Journal of Medicine. 2023;388(1):9-21. Source
  4. 4.Sims, J. R., Zimmer, J. A., Evans, C. D., et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512-527. Source

About the author

Dr. Marissa McCarthy

Board certified in Physical Medicine & Rehabilitation with sub-specialty certification in Brain Injury Medicine. Founder of Raeven Health, a concierge practice in Tampa, Florida.

Read full bio
Raeven HealthRaeven Health

A concierge telemedicine practice led by Dr. Marissa McCarthy, board certified in Physical Medicine & Rehabilitation with sub-specialty certification in Brain Injury Medicine. Based in Tampa and serving patients throughout Florida via secure telehealth.

  • Tampa, Florida · Serving patients statewide
  • By appointment only
  • info@raevenhealth.com
  • Fax: 561-769-2551

© 2026 Raeven Health. All rights reserved.

Hablamos Español

Concierge care • Tampa, FL · Telehealth throughout Florida